Obsidian Therapeutics

Aspires to extend adoptive immunotherapy.

Launch date

2015

Employees

Market cap

Enterprise valuation

Cambridge Massachusetts (HQ)

http://obsidiantx.com/

https://twitter.com/obsidian_tx https://www.linkedin.com/company/obsidian-therapeutics

View job openings

Date	Investors	Amount	Round
-	ShangPharma Innovation Takeda Pivotal Life Sciences Vertex Ventures HC	N/A	-
Dec 2017	Atlas Venture GV Takeda Ventures ShangPharma Amgen Ventures Alexandria Venture Investments	$49.5m	Series A
Sep 2021	Atlas Venture The Column Group Bristol-Myers Squibb Amgen Ventures RA Capital Management	$115m	Series B
Apr 2024*	Atlas Venture Wellington Management Bristol-Myers Squibb Foresite Capital Novo Holdings RTW Investments RA Capital Management Janus Henderson Investors Samsara BioCapital T. Rowe Price Logos Capital Woodline Partners Surveyor Capital TCGX Deep Track Capital Blue Owl Capital Paradigm BioCapital	$161m	Series C
Total Funding		€295m

Tech stackLearn more about the technologies and tools that this company uses.